SDZ NVI 085, an α1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties

This publication has 8 references indexed in Scilit:

• The pharmacology and distribution of human 5‐hydroxytryptamine_2B (5‐HT_2b) receptor gene products: comparison with 5‐HT_2a and 5‐HT_2c receptors
  British Journal of Pharmacology, 1995
• Is SDZ NVI-085 an α1-adrenoceptor subtype-selective agonist?
  Life Sciences, 1994
• The Cheng-Prusoff relationship: something lost in the translation
  Trends in Pharmacological Sciences, 1993
• The adrenoceptor agonist, SDZ NVI 085, discriminates between α1A- and α1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat
  European Journal of Pharmacology, 1992
• Centrally acting .alpha.1-adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines
  Journal of Medicinal Chemistry, 1992
• Effects of SDZ NVI-085, a putative subtype-selective α1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep
  European Journal of Pharmacology, 1991
• Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant
  British Journal of Pharmacology, 1986
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973